AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 10924629 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 95
Study 8922912 — intervention group
Group type: EXPERIMENTAL
Intervention: Lisinopril treatment for 6 weeks
Number of subjects: 8619
Study 8922912 — intervention group
Group type: COMPARATOR
Intervention: Control (no lisinopril)
Number of subjects: 8619
Study 1416011 — intervention group
Group type: COMPARATOR
Intervention: 0.9% NaCl (group A)
Number of subjects: 90
Study 1416011 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.12 mg Cl (group B)
Number of subjects: 90
Study 1416011 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.24 mg Cl (group C)
Number of subjects: 90
Study 2860687 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonabine (5, 10, and 15 mg)
Number of subjects: 0
Study 2860687 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketazolam (30 and 45 mg)
Number of subjects: 0
Study 31051465 — intervention group
Group type: EXPERIMENTAL
Intervention: Semisitting position
Number of subjects: 97
Study 31051465 — intervention group
Group type: COMPARATOR
Intervention: Supine position
Number of subjects: 97
Study 29016868 — intervention group
Group type: EXPERIMENTAL
Intervention: Lubiprostone 24 mcg twice daily for 12 weeks
Number of subjects: 0
Study 29016868 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 29016868 — intervention group
Group type: EXPERIMENTAL
Intervention: Lubiprostone
Number of subjects: 0
Study 26806825 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive blood pressure control
Number of subjects: 0
Study 26806825 — intervention group
Group type: COMPARATOR
Intervention: Standard blood pressure control
Number of subjects: 0
Study 25351370 — intervention group
Group type: EXPERIMENTAL
Intervention: cDMARDs
Number of subjects: 205
Study 25351370 — intervention group
Group type: COMPARATOR
Intervention: TNFis
Number of subjects: 205
Study 23683993 — intervention group
Group type: EXPERIMENTAL
Intervention: Duloxetine
Number of subjects: 5627
Study 23683993 — intervention group
Group type: COMPARATOR
Intervention: Comparator arms (paroxetine, venlafaxine, escitalopram)
Number of subjects: 5627
Study 23683993 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5627
Study 20354459 — intervention group
Group type: EXPERIMENTAL
Intervention: Allovectin-7 (2 mg, high dose)
Number of subjects: 133
Study 19265758 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-body vibration at 2 Hz
Number of subjects: 15
Study 19265758 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-body vibration at 26 Hz
Number of subjects: 15
Study 16030045 — intervention group
Group type: EXPERIMENTAL
Intervention: FX dialyzer
Number of subjects: 35
Study 16030045 — intervention group
Group type: COMPARATOR
Intervention: Standard high flux dialysis (SHF)
Number of subjects: 35
Study 14668075 — intervention group
Group type: EXPERIMENTAL
Intervention: bupropion SR (150 or 300 mg) and behavioral counseling (tailored mailings or proactive telephone counseling)
Number of subjects: 1524
Study 14668075 — intervention group
Group type: EXPERIMENTAL
Intervention: tailored mailings
Number of subjects: 1524
Study 14668075 — intervention group
Group type: EXPERIMENTAL
Intervention: bupropion SR (lower dose)
Number of subjects: 1524
Study 14668075 — intervention group
Group type: EXPERIMENTAL
Intervention: lifetime depression
Number of subjects: 1524
Study 10780310 — intervention group
Group type: EXPERIMENTAL
Intervention: Bemiparin (3,500 anti-Xa IU daily)
Number of subjects: 300
Study 10780310 — intervention group
Group type: COMPARATOR
Intervention: UFH (5,000 IU twice daily)
Number of subjects: 300
Study 10780310 — intervention group
Group type: EXPERIMENTAL
Intervention: Bemiparin
Number of subjects: 300
Study 10780310 — intervention group
Group type: COMPARATOR
Intervention: UFH
Number of subjects: 300
Study 8639078 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser photocoagulation of extrafoveal and juxtafoveal CNV
Number of subjects: 516
Study 1521812 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone 0.1% eye drops, 5 times daily for 5 days
Number of subjects: 20
Study 1521812 — intervention group
Group type: COMPARATOR
Intervention: Prednisolone acetate 1.0% eye drops, 5 times daily for 5 days
Number of subjects: 20
Study 3511877 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyproheptadine hydrochloride
Number of subjects: 72
Study 3511877 — intervention group
Group type: EXPERIMENTAL
Intervention: Amitriptyline hydrochloride
Number of subjects: 72
Study 3511877 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study 29889310 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxcarbazepine (OXC)
Number of subjects: 38
Study 29889310 — intervention group
Group type: EXPERIMENTAL
Intervention: Levetiracetam (LEV)
Number of subjects: 38
Study 29889310 — intervention group
Group type: EXPERIMENTAL
Intervention: Lamotrigine (LTG)
Number of subjects: 38
Study 29889310 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 38
Study 29889310 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with epilepsy (before treatment)
Number of subjects: 38
Study 29889310 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with epilepsy (after treatment)
Number of subjects: 38
Study 27647715 — intervention group
Group type: EXPERIMENTAL
Intervention: Baby-Led Introduction to SolidS (BLISS)
Number of subjects: 206
Study 27647715 — intervention group
Group type: COMPARATOR
Intervention: Control (usual care)
Number of subjects: 206
Study 25213665 — intervention group
Group type: EXPERIMENTAL
Intervention: Attention Training Technique (ATT)
Number of subjects: 76
Study 25213665 — intervention group
Group type: COMPARATOR
Intervention: Mindfulness-based task
Number of subjects: 76
Study 22579817 — intervention group
Group type: EXPERIMENTAL
Intervention: Tryptophan (TrpD) depletion
Number of subjects: 28
Study 22579817 — intervention group
Group type: COMPARATOR
Intervention: Sham depletion
Number of subjects: 28
Study 21030704 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic endovascular long-term normothermia
Number of subjects: 102
Study 21030704 — intervention group
Group type: COMPARATOR
Intervention: Conventional temperature management (stepwise fever management with antiinflammatory drugs and surface cooling)
Number of subjects: 102
Study 21030704 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonsteroidal antiinflammatory drugs (used as additional treatment of fever)
Number of subjects: 102
Study 15882239 — intervention group
Group type: EXPERIMENTAL
Intervention: Proton pump inhibitor-start (omeprazole 20 mg daily for 4-8 weeks, then stepped up to omeprazole 40 or 20 mg daily for persistent symptoms)
Number of subjects: 390
Study 15882239 — intervention group
Group type: COMPARATOR
Intervention: H2-receptor antagonist-start (ranitidine 150 mg bid for 4-8 weeks, then stepped up to omeprazole for persistent symptoms)
Number of subjects: 390
Study 15882239 — intervention group
Group type: EXPERIMENTAL
Intervention: Proton pump inhibitor-start
Number of subjects: 390
Study 15882239 — intervention group
Group type: COMPARATOR
Intervention: H2-receptor antagonist-start
Number of subjects: 390
Study 12864764 — intervention group
Group type: EXPERIMENTAL
Intervention: Patented special butterbur root extract
Number of subjects: 0
Study 12864764 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 10421666 — intervention group
Group type: EXPERIMENTAL
Intervention: Lamivudine 100 mg orally daily for 12 months
Number of subjects: 5
Study 10421666 — intervention group
Group type: EXPERIMENTAL
Intervention: Lamivudine treatment
Number of subjects: 5
Study 10421666 — intervention group
Group type: EXPERIMENTAL
Intervention: Lamivudine stopped
Number of subjects: 5
Study 8556545 — intervention group
Group type: EXPERIMENTAL
Intervention: HBV antigens (HBsAg, HBcAg, HBeAg) detected in MN patients
Number of subjects: 67
Study 8556545 — intervention group
Group type: COMPARATOR
Intervention: Control group of 30 randomly selected MsPGN patients
Number of subjects: 67
Study 8556545 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of HBV antigen positivity rates
Number of subjects: 67
Study 8556545 — intervention group
Group type: EXPERIMENTAL
Intervention: Age-related differences in HBV antigen detection
Number of subjects: 67
Study 2508163 — intervention group
Group type: EXPERIMENTAL
Intervention: Moclobemide (Ro 11‐1163)
Number of subjects: 16
Study 773584 — intervention group
Group type: EXPERIMENTAL
Intervention: Guanabenz
Number of subjects: 17
Study 30212814 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 L of clear liquids (Group A)
Number of subjects: 245
Study 30212814 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 L of PEG (Group B)
Number of subjects: 245
Study 30212814 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 L of PEG (Group C)
Number of subjects: 245
Study 29101143 — intervention group
Group type: EXPERIMENTAL
Intervention: Operation Smoke Storm (three 50 min classroom-based sessions in year 7, a family booklet, and a 1-hour booster session in year 8)
Number of subjects: 0
Study 29101143 — intervention group
Group type: COMPARATOR
Intervention: Control schools
Number of subjects: 0
Study 29101143 — intervention group
Group type: EXPERIMENTAL
Intervention: Operation Smoke Storm
Number of subjects: 0
Study 25812845 — intervention group
Group type: EXPERIMENTAL
Intervention: Battery-powered SCDs
Number of subjects: 67
Study 25812845 — intervention group
Group type: COMPARATOR
Intervention: Standard SCDs
Number of subjects: 67
Study 24139854 — intervention group
Group type: EXPERIMENTAL
Intervention: Minocycline 200mg
Number of subjects: 12
Study 24139854 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 21696353 — intervention group
Group type: EXPERIMENTAL
Intervention: Quick-release bromocriptine (bromocriptine-QR)
Number of subjects: 0
Study 21696353 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 18431118 — intervention group
Group type: EXPERIMENTAL
Intervention: Part task training (PTT) and variable priority training (VPT)
Number of subjects: 22
Study 18431118 — intervention group
Group type: COMPARATOR
Intervention: Standard didactic and simulation-based training
Number of subjects: 22
Study 16923230 — intervention group
Group type: EXPERIMENTAL
Intervention: Pea-fibre/FOS formula (10 g/l pea-fibre and 5 g/l fructo-oligosaccharides)
Number of subjects: 11
Study 16923230 — intervention group
Group type: COMPARATOR
Intervention: Standard formula
Number of subjects: 11
Study 12893078 — intervention group
Group type: EXPERIMENTAL
Intervention: Folic acid 5mg once daily for 1 year
Number of subjects: 20
Study 12893078 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 12893078 — intervention group
Group type: EXPERIMENTAL
Intervention: Folic acid
Number of subjects: 20
Study 10851374 — intervention group
Group type: EXPERIMENTAL
Intervention: Lamotrigine (300 mg per day after titration from 25 mg per day over 7 weeks)
Number of subjects: 42
Study 10851374 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study 10851374 — intervention group
Group type: EXPERIMENTAL
Intervention: Lamotrigine
Number of subjects: 42
Study 9176537 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporin A
Number of subjects: 12
Study 9176537 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 8267816 — intervention group
Group type: EXPERIMENTAL
Intervention: Vibroacoustic stimulation
Number of subjects: 35
Study 8267816 — intervention group
Group type: COMPARATOR
Intervention: Control (quiet sleep)
Number of subjects: 35
Study 3711252 — intervention group
Group type: EXPERIMENTAL
Intervention: Annual multiphasic health checkups (MHCs)
Number of subjects: 5156
Study 3711252 — intervention group
Group type: COMPARATOR
Intervention: Control group (not urged to have MHCs)
Number of subjects: 5156
Study 29221643 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking in a traffic-free area (Hyde Park)
Number of subjects: 119
Study 29221643 — intervention group
Group type: COMPARATOR
Intervention: Walking down a traffic-polluted road (Oxford Street)
Number of subjects: 119
Study 29588936 — intervention group
Group type: EXPERIMENTAL
Intervention: cathodal transcranial direct-current stimulation (c-tDCS)
Number of subjects: 29
Study 29588936 — intervention group
Group type: COMPARATOR
Intervention: sham tDCS
Number of subjects: 29
Study 25419887 — intervention group
Group type: EXPERIMENTAL
Intervention: Heatwrap
Number of subjects: 61
Study 25419887 — intervention group
Group type: COMPARATOR
Intervention: Oral placebo
Number of subjects: 61
Study 22588927 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose ATG-F (30 mg/kg)
Number of subjects: 64
Study 22588927 — intervention group
Group type: COMPARATOR
Intervention: Low-dose ATG-F (15 mg/kg)
Number of subjects: 64
Study 20484157 — intervention group
Group type: EXPERIMENTAL
Intervention: E2 supplementation
Number of subjects: 10
Study 18175750 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraduodenal glucose (64 g)
Number of subjects: 8
Study 18175750 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraduodenal fat (10% oil emulsion)
Number of subjects: 8
Study 18175750 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraduodenal protein (72 g whey)
Number of subjects: 8
Study 18175750 — intervention group
Group type: COMPARATOR
Intervention: Intraduodenal saline (0.9%)
Number of subjects: 8
Study 18175750 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraduodenal glucose, fat, and protein
Number of subjects: 8
Study 15855288 — intervention group
Group type: EXPERIMENTAL
Intervention: Hi5+ family fruit and vegetable promotion program
Number of subjects: 575
Study 11839882 — intervention group
Group type: EXPERIMENTAL
Intervention: ICE guided ablation (Group B)
Number of subjects: 40
Study 11839882 — intervention group
Group type: COMPARATOR
Intervention: Conventional ablation (Group A)
Number of subjects: 40
Study 10423464 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral ciprofloxacin plus amoxicillin-clavulanate
Number of subjects: 116
Study 10423464 — intervention group
Group type: COMPARATOR
Intervention: Intravenous ceftazidime
Number of subjects: 116
Study 10423464 — intervention group
Group type: COMPARATOR
Intervention: Placebo (not explicitly mentioned but implied as control for intolerance)
Number of subjects: 116
Study 7589769 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose intravenous immunoglobulin (500 mg/kg)
Number of subjects: 41
Study 7589769 — intervention group
Group type: COMPARATOR
Intervention: Control (nothing given)
Number of subjects: 41
Study 1979923 — intervention group
Group type: EXPERIMENTAL
Intervention: IV dose of 25 mg
Number of subjects: 12
Study 1979923 — intervention group
Group type: EXPERIMENTAL
Intervention: IV dose of 5 mg to 20 mg
Number of subjects: 12
Study 1979923 — intervention group
Group type: EXPERIMENTAL
Intervention: IV dose
Number of subjects: 12
Study 1979923 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral dose
Number of subjects: 12
Study 6928953 — intervention group
Group type: EXPERIMENTAL
Intervention: Reinforced group (Group 3) received a dental health education program with repetition and reinforcement, including two additional visits and a final summary lecture.
Number of subjects: 61
Study 6928953 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonreinforced group (Group 2) received one lecture and a toothbrushing lesson without repetition or reinforcement.
Number of subjects: 61
Study 6928953 — intervention group
Group type: COMPARATOR
Intervention: Control group (Group I) received no oral hygiene lectures or instructions until the conclusion of the experiment.
Number of subjects: 61
Study 31574269 — intervention group
Group type: EXPERIMENTAL
Intervention: Animal welfare information
Number of subjects: 1250
Study 31574269 — intervention group
Group type: EXPERIMENTAL
Intervention: Environmental sustainability information
Number of subjects: 1250
Study 31574269 — intervention group
Group type: COMPARATOR
Intervention: No information
Number of subjects: 1250
Study 31574269 — intervention group
Group type: COMPARATOR
Intervention: Quality information
Number of subjects: 1250
Study 31574269 — intervention group
Group type: COMPARATOR
Intervention: Production cost information
Number of subjects: 1250
Study 31089805 — intervention group
Group type: COMPARATOR
Intervention: 3 in 1 regional pain catheter (C)
Number of subjects: 121
Study 31089805 — intervention group
Group type: EXPERIMENTAL
Intervention: Local infiltration anesthesia (L)
Number of subjects: 121
Study 30174413 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicorandil
Number of subjects: 146
Study 30174413 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 146
Study 26855404 — intervention group
Group type: EXPERIMENTAL
Intervention: Mild psychological stress induced by a short mental arithmetic (MA) test
Number of subjects: 5
Study 26855404 — intervention group
Group type: COMPARATOR
Intervention: Relaxation period (control)
Number of subjects: 5
Study 25175985 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental practice (imagining movements of the fractured upper extremity)
Number of subjects: 0
Study 25175985 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirror therapy (performing functional movement synergies using the unaffected forearm, wrist, and hand)
Number of subjects: 0
Study 25175985 — intervention group
Group type: COMPARATOR
Intervention: Relaxation training (control group)
Number of subjects: 0
Study 25175985 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (including usual care by the general practitioner)
Number of subjects: 0
Study 21931956 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated education and counseling intervention to reduce behavioral and psychosocial risks (BPSR)
Number of subjects: 1044
Study 21931956 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UCG)
Number of subjects: 1044
Study 21931956 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated education and counseling intervention to reduce BPSR
Number of subjects: 1044
Study 21159375 — intervention group
Group type: EXPERIMENTAL
Intervention: Collaborative stepped-care intervention led by lay health counsellors, supplemented by antidepressant drugs; duration: 6 months
Number of subjects: 1160
Study 21159375 — intervention group
Group type: COMPARATOR
Intervention: Enhanced usual care (control group)
Number of subjects: 1160
Study 21159375 — intervention group
Group type: EXPERIMENTAL
Intervention: Collaborative stepped-care intervention in public facilities
Number of subjects: 1160
Study 21159375 — intervention group
Group type: COMPARATOR
Intervention: Enhanced usual care in public facilities
Number of subjects: 1160
Study 21159375 — intervention group
Group type: EXPERIMENTAL
Intervention: Collaborative stepped-care intervention in private facilities
Number of subjects: 1160
Study 21159375 — intervention group
Group type: COMPARATOR
Intervention: Enhanced usual care in private facilities
Number of subjects: 1160
Study 21159375 — intervention group
Group type: EXPERIMENTAL
Intervention: Collaborative stepped-care intervention
Number of subjects: 1160
Study 21159375 — intervention group
Group type: COMPARATOR
Intervention: Enhanced usual care
Number of subjects: 1160
Study 17414601 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibrin glue application
Number of subjects: 300
Study 16340378 — intervention group
Group type: EXPERIMENTAL
Intervention: Levodopa (100 mg)
Number of subjects: 10
Study 16340378 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 12147144 — intervention group
Group type: EXPERIMENTAL
Intervention: Negotiated Telephone Support (NTS) with continued routine management (Group 2)
Number of subjects: 79
Study 12147144 — intervention group
Group type: EXPERIMENTAL
Intervention: Negotiated Telephone Support (NTS) with annual clinic (Group 3)
Number of subjects: 79
Study 12147144 — intervention group
Group type: COMPARATOR
Intervention: Control group with continued routine management (Group 1)
Number of subjects: 79
Study 12147144 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 79
Study 9474309 — intervention group
Group type: EXPERIMENTAL
Intervention: Silicone lens implants
Number of subjects: 64
Study 9474309 — intervention group
Group type: COMPARATOR
Intervention: PMMA lens implants
Number of subjects: 64
Study 9474309 — intervention group
Group type: EXPERIMENTAL
Intervention: Both lens types
Number of subjects: 64
Study 7533223 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxonidine 0.4 mg once daily
Number of subjects: 160
Study 7533223 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide 25 mg once daily
Number of subjects: 160
Study 7533223 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of moxonidine 0.4 mg and hydrochlorothiazide 25 mg
Number of subjects: 160
Study 7533223 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 160
Study 3064779 — intervention group
Group type: EXPERIMENTAL
Intervention: RT + 12 cycles of cyclophosphamide (C)
Number of subjects: 1028
Study 3064779 — intervention group
Group type: EXPERIMENTAL
Intervention: RT + 12 cycles of cyclophosphamide, methotrexate and 5‐fluorouracil (CMF)
Number of subjects: 1028
Study 3064779 — intervention group
Group type: COMPARATOR
Intervention: RT alone (control)
Number of subjects: 1028
Study 28942705 — intervention group
Group type: EXPERIMENTAL
Intervention: Plaster cast removal and immediate mobilization after 10 days
Number of subjects: 109
Study 28942705 — intervention group
Group type: COMPARATOR
Intervention: Continued plaster cast fixation for another 3 weeks
Number of subjects: 109
Study 26508680 — intervention group
Group type: EXPERIMENTAL
Intervention: Levocarnitine therapy (20mg/kg/d for 12 months)
Number of subjects: 222
Study 26508680 — intervention group
Group type: COMPARATOR
Intervention: Control group (no levocarnitine therapy)
Number of subjects: 222
Study 26508680 — intervention group
Group type: EXPERIMENTAL
Intervention: Levocarnitine therapy
Number of subjects: 222
Study 24424629 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 Gy
Number of subjects: 199
Study 24424629 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.0 Gy
Number of subjects: 199
Study 22683042 — intervention group
Group type: EXPERIMENTAL
Intervention: ERN/LRPT 1 g/20 mg/day from 0 to 4 weeks and then ERN/LRPT 2 g/40 mg/day from 5 to 32 weeks
Number of subjects: 1152
Study 22683042 — intervention group
Group type: COMPARATOR
Intervention: ERN 2 g/day without LRPT from 21 to 32 weeks
Number of subjects: 1152
Study 22683042 — intervention group
Group type: COMPARATOR
Intervention: Placebo for the entire study
Number of subjects: 1152
Study 20725588 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin glargine (IG; Lantus)
Number of subjects: 0
Study 20725588 — intervention group
Group type: COMPARATOR
Intervention: Insulin detemir (ID; Levemir)
Number of subjects: 0
Study 18523643 — intervention group
Group type: EXPERIMENTAL
Intervention: bivalent killed whole cell oral cholera vaccine
Number of subjects: 201